Opioids only provide small, short-lasting relief or are ineffective for many acute pain conditions, an overview of systematic ...

A sweeping review of previous research suggests commonly prescribed opioids often provide only modest pain relief and may increase side effect risk.

The difference between public and private [health sectors] is like night and day when it comes to managing acute pain” ...

The world's largest review of opioid pain relievers prescribed for acute pain found these medicines provide only small, short-term relief for some acute conditions and are ineffective for some others.

Chronic pain often gets the spotlight, but acute pain matters, too. Pain after surgery or an injury isn’t something to ignore or “power through” with the expectation that it’ll eventually go away.

Credit: Getty Images Researchers assessed the safety and efficacy of suzetrigine, a non-opioid pain signal inhibitor, on moderate to severe acute pain from in patients with surgical and nonsurgical ...

Pain has the potential to affect various aspects of a person’s life, from disrupting one’s daily routine to negatively impacting emotional well-being. It’s also one of the most common reasons that ...

Intravenous morphine plus acetaminophen provides greater early pain reduction and requires fewer rescue doses than morphine alone in the emergency department, a trial finds.

A stubbed toe, a bruised rib, or a strep-induced sore throat brings what doctors call acute pain—it has an obvious cause and goes away as soon as the issue is healed. Knowing how to treat this type of ...

If you’ve ever twisted your ankle, accidentally cut yourself, or had a toothache, you’ve probably experienced acute pain — a temporary sensation that usually comes on suddenly and can be intense.

SHANGHAI--(BUSINESS WIRE)--Xgene Pharmaceutical announced additional insights into the positive results of a multiple-center, placebo-controlled, dose-ranging Phase 2b study (registration number: ...

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...